Abeona Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Abeona Therapeutics Inc.‘s stocks are currently a part of 19 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 1.42M shares of Abeona Therapeutics Inc.. Compared to the previous quarter, the number fell by -82.60% or -6.75M shares fewer. As for the holding position changes, 21.05% (4) of current hedge fund investors increased the number of shares held, 21.05% (4) of current holders sold a part of the shares held, and 36.84% (7) closed the holdings completely. 4 hedge funds are new holders of Abeona Therapeutics Inc. stock in Q1 2023, it is 21.05% of total holders.
Hedge funds holding Abeona Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 92 |
|---|---|
| Q3 2018 | 104 |
| Q4 2018 | 99 |
| Q1 2019 | 85 |
| Q2 2019 | 92 |
| Q3 2019 | 78 |
| Q4 2019 | 87 |
| Q1 2020 | 79 |
| Q2 2020 | 79 |
| Q3 2020 | 73 |
| Q4 2020 | 69 |
| Q1 2021 | 70 |
| Q2 2021 | 66 |
| Q3 2021 | 54 |
| Q4 2021 | 45 |
| Q1 2022 | 48 |
| Q2 2022 | 37 |
| Q3 2022 | 21 |
| Q4 2022 | 39 |
| Q1 2023 | 19 |
Hedge funds changes in Abeona Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 16 | 37 | 23 | 12 | 4 |
|---|---|---|---|---|---|
| Q3 2018 | 21 | 35 | 24 | 8 | 16 |
| Q4 2018 | 21 | 23 | 34 | 24 | -3 |
| Q1 2019 | 2 | 24 | 29 | 17 | 13 |
| Q2 2019 | 25 | 33 | 12 | 15 | 7 |
| Q3 2019 | 9 | 27 | 23 | 24 | -5 |
| Q4 2019 | 27 | 33 | 11 | 18 | -2 |
| Q1 2020 | 13 | 32 | 22 | 21 | -9 |
| Q2 2020 | 11 | 35 | 19 | 11 | 3 |
| Q3 2020 | 9 | 19 | 32 | 15 | -2 |
| Q4 2020 | 12 | 29 | 13 | 15 | 0 |
| Q1 2021 | 15 | 21 | 20 | 13 | 1 |
| Q2 2021 | 17 | 14 | 23 | 22 | -10 |
| Q3 2021 | 6 | 9 | 20 | 17 | 2 |
| Q4 2021 | 13 | 10 | 10 | 23 | -11 |
| Q1 2022 | 10 | 6 | 13 | 7 | 12 |
| Q2 2022 | 3 | 10 | 5 | 14 | 5 |
| Q3 2022 | 18 | 2 | 1 | 33 | -33 |
| Q4 2022 | 22 | 10 | 3 | 5 | -1 |
| Q1 2023 | 4 | 4 | 4 | 7 | 0 |
Hedge funds changes in Abeona Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 9,107,000 | 4,301,000 |
|---|---|---|
| Q3 2018 | 2,637,000 | 2,437,000 |
| Q4 2018 | 1,592,000 | 1,051,000 |
| Q1 2019 | 2,295,000 | 732,000 |
| Q2 2019 | 582,000 | 521,000 |
| Q3 2019 | 802,000 | 220,000 |
| Q4 2019 | 1,484,000 | 390,000 |
| Q1 2020 | 215,000 | 196,000 |
| Q2 2020 | 198,000 | 227,000 |
| Q3 2020 | 65,000 | 21,000 |
| Q4 2020 | 114,000 | 22,000 |
| Q1 2021 | 556,000 | 371,000 |
| Q2 2021 | 209,000 | 204,000 |
| Q3 2021 | 139,000 | 52,000 |
| Q4 2021 | 7,000 | 0 |
| Q1 2022 | 1,000 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |